Skip to main content
SENATE 355119th CongressReferred to the Committee on Foreign Relations. (text: CR S5006)

A resolution requesting information on the Republic of Rwanda's human rights practices pursuant to section 502B(c) of the Foreign Assistance Act of 1961.

Last Action
7/31/2025

Actions

  • 2025-12-17Held at the desk.
  • 2025-12-17Received in the House.
  • 2025-12-17Message on Senate action sent to the House.
  • 2025-12-16Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S8794)
  • 2025-12-16Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
  • 2025-12-16Measure laid before Senate by unanimous consent. (consideration: CR S8793-8794)
  • 2025-12-16Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
  • 2025-12-16Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
  • 2025-02-03Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • 2025-02-03Introduced in Senate

CRS Summary

As of 2025-02-03 (00)

FDA Modernization Act 3.0

This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug. 

The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications, and may make other changes to the regulations as appropriate. 

The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule. 

Cosponsors (9)

  • Eric Schmitt (R-MO)
  • Angus King (I-ME)
  • John Kennedy (R-LA)
  • Sheldon Whitehouse (D-RI)
  • Roger Marshall (R-KS)
  • Richard Blumenthal (D-CT)
  • Rand Paul (R-KY)
  • Ben Luján (D-NM)
  • Adam Schiff (D-CA)

Subjects

  • Administrative law and regulatory procedures
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Medical research
  • Research administration and funding
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.